eamdacademy.org-y2V8-1794356397-e928218527 1794356397 Eurasian Academy of Medicine and Dentistry info@eamdacademy.org Eurasian Academy of Medicine and Dentistry Journal of Applied Pharmaceutical Technologies and Systems J Appl Pharm Technol Syst 3149-9589 2026 5 1 Anna Kowalska Piotr Nowak Tomasz Zielinski Katarzyna Mazur 2026 10.68159/e928218527 https://eamdacademy.org/pub/journal/3/article/e928218527 Kulkarni JA, Cullis PR, Van Der Meel R. Lipid nanoparticles enabling gene therapies: from concepts to clinical utility. Nucleic Acid Ther. 2018;28(3):146-57. Witzigmann D, Kulkarni JA, Leung J, Chen S, Cullis PR, van der Meel R. Lipid nanoparticle technology for therapeutic gene regulation in the liver. Adv Drug Deliv Rev. 2020;159:344-63. Hwang D, Ramsey JD, Kabanov AV. Polymeric micelles for the delivery of poorly soluble drugs: From nanoformulation to clinical approval. Adv Drug Deliv Rev. 2020;156:80-118. Mitchell MJ, Billingsley MM, Haley RM, Wechsler ME, Peppas NA, Langer R. Engineering precision nanoparticles for drug delivery. Nat Rev Drug Discov. 2021;20(2):101-24. Hou X, Zaks T, Langer R, Dong Y. Lipid nanoparticles for mRNA delivery. Nat Rev Mater. 2021;6(12):1078-94. Paunovska K, Loughrey D, Dahlman JE. Drug delivery systems for RNA therapeutics. Nat Rev Genet. 2022;23(5):265-80. Tenchov R, Bird R, Curtze AE, Zhou Q. Lipid nanoparticles─ from liposomes to mRNA vaccine delivery, a landscape of research diversity and advancement. ACS Nano. 2021;15(11):16982-7015. Schoenmaker L, Witzigmann D, Kulkarni JA, Verbeke R, Kersten G, Jiskoot W, et al. mRNA-lipid nanoparticle COVID-19 vaccines: Structure and stability. Int J Pharm. 2021;601:120586. Hua S, De Matos MB, Metselaar JM, Storm G. Current trends and challenges in the clinical translation of nanoparticulate nanomedicines: pathways for translational development and commercialization. Front Pharmacol. 2018;9:790. Anselmo AC, Mitragotri S. Nanoparticles in the clinic: An update. Bioeng Transl Med. 2019;4(3):e10143. Nkanga CI, Fisch A, Rad-Malekshahi M, Romic MD, Kittel B, Ullrich T, et al. Clinically established biodegradable long acting injectables: an industry perspective. Adv Drug Deliv Rev. 2020;167:19-46. Alidori S, Subramanian R, Holm R. Patient-centric long-acting injectable and implantable platforms─ an industrial perspective. Mol Pharm. 2024;21(9):4238-58. Lawrence XY, Kopcha M. The future of pharmaceutical quality and the path to get there. Int J Pharm. 2017;528(1-2):354-9. Arnouts S, Brown S, De Arriba ML, Donabedian M, Charlier J. Technology Readiness Levels for vaccine and drug development in animal health: From discovery to life cycle management. Front Vet Sci. 2022;9:1016959. Kedia SB, Baker JC, Carbonell RG, Lee KH, Roberts CJ, Erickson J, et al. Biomanufacturing readiness levels [BRL]—A shared vocabulary for biopharmaceutical technology development and commercialization. Biotechnol Bioeng. 2022;119(12):3526-36. Cammarano A, Iacono SD, Battisti M, De Stefano L, Meglio C, Nicolais L. A systematic review of microneedles technology in drug delivery through a bibliometric and patent overview. Heliyon. 2024;10(23). Pagani E, Ropke CD, Soares CM, Perez SA, Benevides PJ, Barbosa BS, et al. Technology readiness level roadmap for developing innovative herbal medicinal products. Pharmaceuticals. 2024;17(6):703. Salvador-Carulla L, Woods C, de Miquel C, Lukersmith S. Adaptation of the technology readiness levels for impact assessment in implementation sciences: The TRL-IS checklist. Heliyon. 2024;10(9). Webster A, Gardner J. Aligning technology and institutional readiness: the adoption of innovation. Technol Anal Strateg Manag. 2019;31(10):1229-41. Mdanda S, Ubanako P, Kondiah PP, Kumar P, Choonara YE. Recent advances in microneedle platforms for transdermal drug delivery technologies. Polymers. 2021;13(15):2405. Nazary Abrbekoh F, Salimi L, Saghati S, Amini H, Fathi Karkan S, Moharamzadeh K, et al. Application of microneedle patches for drug delivery; doorstep to novel therapies. J Tissue Eng. 2022;13:20417314221085390. Jung HN, Lee SY, Lee S, Youn H, Im HJ. Lipid nanoparticles for delivery of RNA therapeutics: Current status and the role of in vivo imaging. Theranostics. 2022;12(17):7509. Lopes C, Cristóvão J, Silvério V, Lino PR, Fonte P. Microfluidic production of mRNA-loaded lipid nanoparticles for vaccine applications. Expert Opin Drug Deliv. 2022;19(10):1381-95. Shepherd SJ, Han X, Mukalel AJ, El-Mayta R, Thatte AS, Wu J, et al. Throughput-scalable manufacturing of SARS-CoV-2 mRNA lipid nanoparticle vaccines. Proc Natl Acad Sci USA. 2023;120(33):e2303567120. Bannigan P, Bao Z, Hickman RJ, Aldeghi M, Häse F, Aspuru-Guzik A, et al. Machine learning models to accelerate the design of polymeric long-acting injectables. Nat Commun. 2023;14(1):35. Niazi SK. The United States Food and Drug Administration’s platform technology designation to expedite the development of drugs. Pharmaceutics. 2024;16(7):918. Lu RM, Hsu HE, Perez SJ, Kumari M, Chen GH, Hong MH, et al. Current landscape of mRNA technologies and delivery systems for new modality therapeutics. J Biomed Sci. 2024;31(1):89. Begines B, Ortiz T, Pérez-Aranda M, Martínez G, Merinero M, Argüelles-Arias F, et al. Polymeric nanoparticles for drug delivery: Recent developments and future prospects. Nanomaterials. 2020;10(7):1403. Nele V, Campani V, Moosavian SA, De Rosa G. Lipid nanoparticles for RNA delivery: Self-assembling vs driven-assembling strategies. Adv Drug Deliv Rev. 2024;208:115291. Larrañeta E, Domínguez-Robles J. Long-acting drug delivery systems: Current landscape and future prospects. Drug Discov Today. 2025:104447. Horvath D, Basler M. PLGA particles in immunotherapy. Pharmaceutics. 2023;15(2):615.